46 related articles for article (PubMed ID: 26431981)
1. Effect of the human papillomavirus vaccine on the risk of genital warts: a nationwide cohort study of South Korean adolescent girls.
Cho J; Kim EM; Kim J; Shin JY; Kim EH; Park JH; Kwon SL; Kwon GY; Shin SA; Kim J
Epidemiol Health; 2024 Mar; ():e2024040. PubMed ID: 38549356
[TBL] [Abstract][Full Text] [Related]
2. Estimating the Effect of Genital vs Extragenital Warts on Immunocompetent Indian Adult Patients; Quality of Life: A Comparative Cross-Sectional Study.
Rani N; Kumar P; Mishra AK; Saifuddin R; Abhishek MP; Tiwari R
J Pharm Bioallied Sci; 2024 Feb; 16(Suppl 1):S299-S301. PubMed ID: 38595382
[TBL] [Abstract][Full Text] [Related]
3. Impact of quadrivalent human papillomavirus vaccine on genital warts in an opportunistic vaccination structure.
Lurie S; Mizrachi Y; Chodick G; Katz R; Schejter E
Gynecol Oncol; 2017 Aug; 146(2):299-304. PubMed ID: 28602548
[TBL] [Abstract][Full Text] [Related]
4. Will cervical screening remain cost-effective in women offered the next generation nonavalent HPV vaccine? Results for four developed countries.
Simms KT; Smith MA; Lew JB; Kitchener HC; Castle PE; Canfell K
Int J Cancer; 2016 Dec; 139(12):2771-2780. PubMed ID: 27541596
[TBL] [Abstract][Full Text] [Related]
5. A Bivariate Mixture Model for Natural Antibody Levels to Human Papillomavirus Types 16 and 18: Baseline Estimates for Monitoring the Herd Effects of Immunization.
Vink MA; Berkhof J; van de Kassteele J; van Boven M; Bogaards JA
PLoS One; 2016; 11(8):e0161109. PubMed ID: 27537200
[TBL] [Abstract][Full Text] [Related]
6. The Potential Benefits of HPV Vaccination in Previously Infected Women.
Schiller JT
EBioMedicine; 2016 Aug; 10():5-6. PubMed ID: 27515688
[No Abstract] [Full Text] [Related]
7. Effectiveness of a universal vaccination program with an HPV quadrivalent vaccine in young Brazilian women.
Wendland EM; Kops NL; Bessel M; Comerlato J; Maranhão AGK; Souza FMA; Villa LL; Pereira GFM
Vaccine; 2021 Mar; 39(13):1840-1845. PubMed ID: 33674171
[TBL] [Abstract][Full Text] [Related]
8. Comparison of different human papillomavirus (HPV) vaccine types and dose schedules for prevention of HPV-related disease in females and males.
Bergman H; Buckley BS; Villanueva G; Petkovic J; Garritty C; Lutje V; Riveros-Balta AX; Low N; Henschke N
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31755549
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of catch-up human papillomavirus vaccination on incident cervical neoplasia in a US health-care setting: a population-based case-control study.
Silverberg MJ; Leyden WA; Lam JO; Gregorich SE; Huchko MJ; Kulasingam S; Kuppermann M; Smith-McCune KK; Sawaya GF
Lancet Child Adolesc Health; 2018 Oct; 2(10):707-714. PubMed ID: 30236379
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of HPV vaccines against genital warts in women from Valencia, Spain.
Navarro-Illana E; López-Lacort M; Navarro-Illana P; Vilata JJ; Diez-Domingo J
Vaccine; 2017 Jun; 35(25):3342-3346. PubMed ID: 28499554
[TBL] [Abstract][Full Text] [Related]
11. Human Papillomavirus Vaccine Impact and Effectiveness in Six High-Risk Populations: A Systematic Literature Review.
Goodman E; Reuschenbach M; Kaminski A; Ronnebaum S
Vaccines (Basel); 2022 Sep; 10(9):. PubMed ID: 36146620
[TBL] [Abstract][Full Text] [Related]
12. Partial Protective Effect of Bivalent Human Papillomavirus 16/18 Vaccination Against Anogenital Warts in a Large Cohort of Dutch Primary Care Patients.
Woestenberg PJ; Guevara Morel AE; Bogaards JA; Hooiveld M; Schurink-van 't Klooster TM; Hoebe CJPA; van der Sande MAB; van Benthem BHB
Clin Infect Dis; 2021 Jul; 73(2):291-297. PubMed ID: 32421775
[TBL] [Abstract][Full Text] [Related]
13. Epidemiology of genital warts in the British population: implications for HPV vaccination programmes.
Sonnenberg P; Tanton C; Mesher D; King E; Beddows S; Field N; Mercer CH; Soldan K; Johnson AM
Sex Transm Infect; 2019 Aug; 95(5):386-390. PubMed ID: 30723185
[TBL] [Abstract][Full Text] [Related]
14. Application of real-time global media monitoring and 'derived questions' for enhancing communication by regulatory bodies: the case of human papillomavirus vaccines.
Bahri P; Fogd J; Morales D; Kurz X;
BMC Med; 2017 May; 15(1):91. PubMed ID: 28464900
[TBL] [Abstract][Full Text] [Related]
15. Impact of quadrivalent human papillomavirus vaccine in women at increased risk of genital warts burden: Population-based cross-sectional survey of Czech women aged 16 to 40 years.
Petráš M; Adámková V
Vaccine; 2015 Nov; 33(46):6264-7. PubMed ID: 26431981
[TBL] [Abstract][Full Text] [Related]
16. Early direct and indirect impact of quadrivalent HPV (4HPV) vaccine on genital warts: a systematic review.
Mariani L; Vici P; Suligoi B; Checcucci-Lisi G; Drury R
Adv Ther; 2015 Jan; 32(1):10-30. PubMed ID: 25620536
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the Early Benefit of Quadrivalent HPV Vaccine on Genital Warts in Belgium: A Cohort Study.
Dominiak-Felden G; Gobbo C; Simondon F
PLoS One; 2015; 10(7):e0132404. PubMed ID: 26147096
[TBL] [Abstract][Full Text] [Related]
18. Rates and predictors of genital warts burden in the Czech population.
Petráš M; Adámková V
Int J Infect Dis; 2015 Jun; 35():29-33. PubMed ID: 25869075
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
